Titan Medical [TSE:TMD]
TMD]

The dynamic medical landscape is actively seeking technological advancements that make surgical procedures easier for surgeons and safer for patients. In that regard, minimally invasive surgery (MIS) has gained popularity in recent years; in comparison to conventional, open surgeries, MIS reduces risk and potential co-morbidities. On the flipside, however, MIS requires increased surgical expertise; specifically manual dexterity and visuomotor control. Restricted workspace and field-of-view—the operative site is projected as a 2D picture rather than the 3D view of the human eye—are additional limitations of MIS. The need to overcome the challenges of MIS has shifted the limelight to robot-assisted surgery. Computer-controlled surgical robots bring greater accuracy and a high degree of dexterity that allow surgeons to make smaller incisions and significantly reduce pain during and after surgery for patients.

Recognizing the tremendous potential of robot-assisted surgery, Titan Medical, a leading medical device company,has developed Enos single access surgery system with the aim to enhance robotic-assisted surgery through technology that requires only one patient access site. “We “We believe that the system will address an under-penetrated but high demand segment of the robot-assisted surgical device market—promising less patient trauma and faster recovery times, and savings on capital equipment, service, and procedure cost for hospitals and ambulatory surgical centers,” states David McNally, president, CEO, and chairman of board, Titan Medical.

A factor that sets the Enos system apart from other robotic systems is its single-access architecture. Unlike multi-port surgical systems, Enos makes just one incision around the umbilicus, leading to a near-scarless surgery.

The surgical system also encompasses two multi-articulating instruments and a dual-view 3D and 2D endoscopic high-definition vision system. The two multi-articulating instruments and a dual-view 3D and 2D endoscopic high-definition vision system.

The two multi-articulating instruments with fluid “snake-like” movement are engineered to facilitate dexterity and ease of movement with appropriate force to perform surgical tasks such as tissue grasping, blunt dissection, cutting, approximation, suturing, coagulation, and ligation. Furthermore, a dual camera fitted to the patient cart adds an element of safety and visualization during initial exploration for surgery by providing a clear view of target anatomy. The icing on the cake is Enos’ ergonomic workstation with 3D high-definition display that facilitates the crucial balance of surgical immersion and situational awareness in the operating room. The Enos system derives its name from the Greek meaning ‘of one’ and represents Titan Medical’s holistic approach to development.

Titan Medical’s goal with the Enos system is to improve patient outcomes, lower operating room costs, and offer an applied technology that is effective and easy to use—allowing medical professionals to perform at their best. “If we are able to complete product development and achieve regulatory clearance in a timely manner, upon commercialization,we expect our single-port system to expand the market for robot-assisted surgery with attractive pricing, a reduced operating room footprint, and greater portability within hospitals,” states McNally. While the Enos single access surgery system is yet to be approved by the U.S. Food and Drug Administration and other regulatory authorities, there is no doubt that Titan Medical’s innovation holds significant promise in revolutionizing the single access surgery and the healthcare industry as a whole.